Chicago Capital’s Tandem Diabetes Care TNDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-20,726
Closed -$397K 364
2025
Q1
$397K Sell
20,726
-949,881
-98% -$27.8M 0.01% 263
2024
Q4
$35M Sell
970,607
-32,540
-3% -$1.1M 0.93% 37
2024
Q3
$42.5M Buy
1,003,147
+182,085
+22% +$7.72M 1.18% 33
2024
Q2
$33.1M Buy
821,062
+149,757
+22% +$6.25M 0.98% 37
2024
Q1
$23.8M Buy
671,305
+194,368
+41% +$5.21M 0.72% 39
2023
Q4
$14.1M Sell
476,937
-427,473
-47% -$8.87M 0.51% 44
2023
Q3
$18.8M Buy
904,410
+791,336
+700% +$21.7M 0.88% 36
2023
Q2
$2.77M Sell
113,074
-189,916
-63% -$6.11M 0.13% 67
2023
Q1
$12.3M Sell
302,990
-25,230
-8% -$1.04M 0.61% 41
2022
Q4
$14.8M Sell
328,220
-151,653
-32% -$6.87M 0.82% 40
2022
Q3
$23M Buy
479,873
+23,870
+5% +$1.31M 1.33% 30
2022
Q2
$27M Sell
456,003
-6,667
-1% -$547K 1.49% 28
2022
Q1
$53.8M Buy
462,670
+4,056
+0.9% +$474K 2.32% 13
2021
Q4
$69M Buy
458,614
+5,341
+1% +$721K 2.57% 12
2021
Q3
$54.1M Sell
453,273
-4,188
-0.9% -$461K 2.05% 19
2021
Q2
$44.6M Sell
457,461
-1,432
-0.3% -$128K 1.74% 28
2021
Q1
$40.5M Buy
458,893
+18,719
+4% +$1.74M 1.71% 27
2020
Q4
$42.1M Sell
440,174
-160
-0% -$16.5K 1.88% 26
2020
Q3
$50M Sell
440,334
-397
-0.1% -$41.7K 2.57% 12
2020
Q2
$43.6M Sell
440,731
-82
-0% -$6.54K 2.53% 12
2020
Q1
$28.4M Sell
440,813
-455
-0.1% -$31.9K 2.29% 18
2019
Q4
$26.3M Buy
441,268
+8,185
+2% +$505K 1.6% 27
2019
Q3
$25.5M Buy
433,083
+206,160
+91% +$13.2M 1.71% 27
2019
Q2
$14.6M Buy
+226,923
New +$14.6M 0.94% 42

Other funds holding TNDM

Chicago Capital's TNDM Position: Q2 2025 in Review

Chicago Capital sold out of Tandem Diabetes Care (TNDM) in Q2 2025, closing a stake of 20,726 shares — an estimated $397K sold.

Chicago Capital first reported a position in TNDM in Q2 2019 and held it in 24 quarters. The position peaked at $69M in Q4 2021. 270 funds tracked by Wall St. Rank hold TNDM as of Q2 2025.

  • Chicago Capital reported no remaining Tandem Diabetes Care position as of Q2 2025 after selling out during the quarter.
  • Chicago Capital sold 20,726 Tandem Diabetes Care shares in Q2 2025, an estimated $397K.
  • Chicago Capital first reported a position in Tandem Diabetes Care in Q2 2019 and held it in 24 quarters.
  • Chicago Capital's Tandem Diabetes Care position peaked at $69M in Q4 2021.
  • 270 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2025.

Based on Chicago Capital's 13F filing for Q2 2025, filed 17 Jul 2025.